42
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15108 |
DG-041
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
DG-041 是高亲和力,选择性的,有效的 EP3受体拮抗剂,在结合和 FLIPR 试验中,IC50分别为 4.6 nM 和 8.1 nM。DG-041通过抑制 PGE2促进血小板聚集。DG-041具有血脑屏障渗透性。 | |||
T0328 |
Hexetidine
NSC-17764,海克替啶 |
Antibacterial; Antifungal | Microbiology/Virology |
Hexetidine (NSC-17764) 是一种口服活性的抗菌抗真菌试剂,可用于口腔感染的相关研究。 | |||
T14369 |
AZD-0284
|
ROR | Metabolism |
AZD-0284 是核受体 (RORγ) 的选择性反向激动剂。它对呼吸道疾病及斑块型寻常型银屑病具有潜在的应用价值。 | |||
T7657 |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat
髓鞘少突胶质细胞糖蛋白,MOG (35-55) |
Others | Others |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) 是中枢神经鞘的一个次要成分。它能诱导强效的 T 细胞和 B 细胞反应,同时是高度脑源性的。它能够引发复发缓解性神经系统疾病,伴有广泛的斑块样脱髓鞘。 | |||
TP2045 |
CH 275
|
||
Potent somatostatin receptor 1 (sst1) agonist; displays selectivity for sst1 (IC50 values are 30.9 nM, 345 nM, > 1 μM, > 10 μM and > 10μM for human sst1, sst3, sst4, sst2 and sst5 respectively). Attenuates somatostatin release in the rat nucleus accumbens | |||
T1000L |
Chlorhexidine diacetate
醋酸氯己定,Hibitane diacetate,Chlorhexidine Acetate,Bactigras |
CAT; Antibacterial; Antibiotic; Antifection | Microbiology/Virology; oxidation-reduction |
Chlorhexidine diacetate (Bactigras) 是一种双胍类杀菌剂,能快速消灭革兰氏阳性菌和革兰氏阴性菌。它也用作漱口水以防止口腔菌斑。 | |||
T68006 |
Orilotimod potassium
APO805K1 |
||
Orilotimod potassium (APO805K1)可用于研究斑块状银屑病。 | |||
T1147 |
Chlorhexidine dihydrochloride
盐酸氯己定,Chlorhexidine hydrochloride,Chlorhexidine 2HCl,NSC-185 |
CAT; Cell wall; Antibacterial; Antibiotic; Antifection | Immunology/Inflammation; Microbiology/Virology; oxidation-reduction |
Chlorhexidine dihydrochloride (NSC-185) 是一种消毒剂和局部抗感染剂,也用作漱口水以防止口腔菌斑。 | |||
T9930 |
Secukinumab
|
IL Receptor | Immunology/Inflammation |
Secukinumab 是一种完全人源化的单克隆抗 IL-17A 抗体,是一个被美国食品和药物管理局批准用于治疗中度至重度斑块型银屑病的抗体。 | |||
T17038 |
Tepilamide fumarate
XP-23829 |
Others | Others |
Tepilamide fumarate (XP-23829) 是一种口服具有活性的延胡索酸酯,可用于研究中度到重度慢性斑块银屑病。 | |||
T37445 |
Etanercept
|
TNF | Apoptosis |
Etanercept is a dimeric fusion protein that serves as a competitive TNF inhibitor by binding to TNF. It effectively inhibits the binding of both TNF-α and TNF-β to the TNF receptors on cell surfaces, thereby rendering TNF biologically inactive. Etanercept has demonstrated efficacy in treating rheumatoid arthritis, juvenile idiopathic arthritis, and plaque psoriasis. | |||
T38105 |
Ixekizumab
LY2439821 |
IL Receptor; Interleukin | Immunology/Inflammation |
Ixekizumab (LY2439821) 是一种人源化 IgG4 单克隆抗体,可选择性结合和中和白细胞介素 IL-17A ,Kd 值<3 pM。Ixekizumab 科阻断 IL-17A 与 IL-17RA 的结合,但不与其他 IL-17 家族成员结合。Ixekizumab 用于治疗中重度斑块型银屑病、银屑病关节炎和牛皮癣。 | |||
T77170 |
Siplizumab
MEDI-507 |
Others | Others |
Siplizumab (MEDI-507) 是一种人源化靶向 CD2 的 IgG1 单克隆抗体。Siplizumab 在体外选择性地消耗效应记忆 T 细胞并促进同种异体反应性调节性 T 细胞的相对扩增。Siplizumab 可用于治疗斑块状银屑病。 | |||
T16094 |
MK-3328
|
Others | Others |
MK-3328 是对β-淀粉样蛋白 (β-Amyloid)具有很高的亲和力(IC50 为 10.5 nM),是一种可作为临床评估β-淀粉样斑块负荷的候选 PET 配体。MK-3328是治疗阿尔茨海默病的潜在药物。 | |||
T0305 |
Erythrosine B
Erythrosine I,Erythrosin extra bluish,Erythrosin B,赤藓红B |
Others | Others |
Erythrosine B (Erythrosine I) 是一种已被用于开发动物模型的新型光敏剂,在食品和纺织工业的人造染料中具有广泛的应用。 | |||
T0578 |
Erythrosin B
Iodeosin,Tetraiodofluorescein,藻红B |
Others | Others |
Erythrosin B (Iodeosin) 是一种四碘荧光素,在某些食物(樱桃、鱼)中用作红色色素,用作某些细胞类型的染色剂,以及用作牙菌斑的披露物。其分子结构与甲状腺素相似。 | |||
T64167 |
Ifebemtinib
IN-10018,BI-853520 |
FAK | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Ifebemtinib (BI-853520) 是一种具有口服活性和强效性的粘附斑激酶 (FAK) 抑制剂 (IC50=1 nM),具有抗肿瘤活性,可抑制恶性胸膜间皮瘤中的球状体形成和原位肿瘤生长,可用于研究乳腺癌和卵巢癌。 | |||
T76924 |
Efalizumab
Hu1124,HU 1124 |
Integrin | Cytoskeletal Signaling |
Efalizumab 是一种新型针对 T 细胞的有效调节剂,是人源化 LFA-1 α 亚基(CD11a)单克隆抗体。Efalizumab 对 T 细胞激活、皮肤T细胞运输和T细胞粘附到角质形成细胞有抑制作用,可用于研究斑块银屑病和银屑病关节炎。 | |||
T0900 |
Cetylpyridinium chloride monohydrate
Hexadecylpyridinium chloride monohydrate,十六烷基氯化吡啶 |
Antibacterial; Antibiotic | Microbiology/Virology |
Cetylpyridinium chloride monohydrate (Hexadecylpyridinium chloride monohydrate) 是阳离子季铵, 是一种能杀死细菌和其他微生物的防腐剂, 用于某些类型的漱口水, 牙膏, 咽喉和鼻腔喷雾剂中, 可有效预防牙斑和减少牙龈炎。 | |||
T68705 |
Salifluor
|
||
Salifluor is a broad spectrum antimicrobial agent that has been investigated for its abilities to inhibit dental plaque formation. | |||
TP1494 |
β-Amyloid (4-10)
β-Amyloid 4-10 |
||
Antibodies corresponding to beta-amyloid (4-10) are effective in vivo inhibitors of cytotoxicity, amyloid plaque formation and special memory disturbances in mice. This peptide does not elicit an inflammatory response. | |||
T68494 | Octenidine saccharin | ||
Octenidine saccharin is a Dental Plaque Inhibitor | |||
T1267L |
Abacavir acetate
KM-133,KM133,KM 133 |
||
Abacavir acetate (Prurisol) has the potential to be used in the treatment of plaque psoriasis. | |||
T38175 |
MPro N3
|
||
Coronavirus main protease (Mpro) inhibitor (respective IC50 values are 2.7, 4 and 8.8 μM for MHV-A29, HCoV-229E and FOPV replication in vitro). Inhibits viral cell infection in an MHV plaque reduction assay. Also inhibits SARS-CoV-2 viral cell entry in a plaque reduction assay (IC50 = 16.8 μM). | |||
T69456 | Melagatran monohydrate | ||
Melagatran monohydrate is a thrombin inhibitor. Melagatran prevents tissue factor expression in human platelet-monocyte heterotypic complexes. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice. | |||
T76885 | Sonelokimab | ||
Sonelokimab (ALX 0761; M 1095) 是三价纳米抗体,特异性结合人白介素(IL)-17A、IL-17F及人血清白蛋白VHH,由单价骆驼来源纳米抗体构成,展现于斑块型银屑病研究中的应用潜力。 | |||
T21814 |
ONO 4817
|
||
ONO-4817 是一种广谱基质金属蛋白酶 (MMP) 抑制剂。抑制基质金属蛋白酶 (MMP) 有望抑制动脉粥样硬化新内膜增殖,从而限制动脉粥样硬化斑块的进展。ONO-4817 抑制实验性高脂血症兔主动脉内膜增生的发展。 | |||
TP2171 |
β-amyloid (12-28) (TFA) (107015-83-8 free base)
Amyloid β-Protein (12-28) (TFA),β-amyloid (12-28) (TFA) |
Others | Others |
β-amyloid (12-28) TFA, a peptide fragment of β-amyloid protein (β1-42), is the major component of senile plaque cores. β-amyloid (12-28) has aggregation properties and the potential for Alzheimer’s disease research. | |||
TP2135 |
cAC 253
|
||
Amylin (AMY3) antagonist (IC50 = 0.3 μM). Protects neuronal cells from Aβ(1-42)-induced cytotoxicity in vitro. Brain penetrant. Improves spatial memory and reduces Aβ plaque number and total area in a mouse Alzheimer's disease model. | |||
T77098 | Netakimab | ||
Netakimab为抗IL-17单克隆抗体。Nerelimomab适用于研究强直性脊柱炎、银屑病关节炎及中重度斑块状银屑病。 | |||
T71306 |
Gemfibrozil-d6
|
||
Gemfibrozil-d6 is intended for use as an internal standard for the quantification of gemfibrozil by GC- or LC-MS. Gemfibrozil is a peroxisome proliferator-activated reporter α and PPARγ agonist. In vivo, gemfibrozil reduces serum total cholesterol, triglyceride, and LDL levels in a rat model of high-cholesterol diet-induced hyperlipidemia. Gemfibrozil reduces atherosclerotic plaque area, superoxide production, and expression of the genes encoding the NF-κB subunit p65 and chemokine (C-C) motif l... | |||
T78298 |
Alefacept
LFA 3TIP,Human LFA 3IgG fusion protein,BG 9273 |
||
Alefacept (BG 9273)为一种人类淋巴细胞功能相关抗原3/免疫球蛋白1融合蛋白,主要在慢性斑块状银屑病研究中使用。 | |||
T69664 | Umibecestat HCl | ||
Umibecestat, also known as CNP-520, is a beta-secretase inhibitor and is a drug candidate for prevention trials in Alzheimer's disease. CNP520 has a selectivity, pharmacodynamics, and distribution profile suitable for AD prevention studies. CNP520 reduced brain and cerebrospinal fluid (CSF) Aβ in rats and dogs, and Aβ plaque deposition in APP-transgenic mice. CNP520 reduces Aβ load and neuroinflammation in APP‐transgenic mice | |||
T75779 |
β-Amyloid (12-28) (TFA)
|
||
β-Amyloid (12-28) (TFA)为β-淀粉样蛋白(β1-42)的肽片段,后者是由42个氨基酸组成,构成老年斑核心的关键蛋白。β-Amyloid (12-28) (TFA)展现出聚集性质,并可能对阿尔茨海默氏病研究具有潜在价值。 | |||
T38118 |
Zanamivir-13C,15N2
Zanamivir-13C,15N2 |
||
Zanamivir-13C,15N2is intended for use as an internal standard for the quantification of zanamivir by GC- or LC-MS. Zanamivir is a sialic acid analog that inhibits neuraminidase release of newly replicated influenza virus particles.1It has been shown to selectively inhibit the growth of influenza A and B viruses in plaque reduction assays with IC50values ranging from 5 to 14 nM and to directly inhibit influenza A and B virus neuraminidases with IC50values ranging from 0.6 to 7.9 nMin vitro. Intra... | |||
T63558 | IRAK4-IN-21 | ||
IRAK4-IN-21 是选择性的、口服具有活力的、强效的 IRAK4 抑制剂,能够作用于 IRAK4 (IC50: 5 nM) 和 TAK1 (IC50: 56 nM)。IRAK4-IN-21 对 IL-23 的产生表现出有效的抑制作用,其 IC50值为0.17 μM。IRAK4-IN-21 能够用于研究自身免疫性疾病,如斑块状银屑病和银屑病关节炎。 | |||
T72893 | AChE/MAO-IN-2 | ||
Dual AChE-MAO B-IN-5 是一种茚满酮衍生物,是一种有效的双重 AChE/MAO-B 抑制剂,对 AChE、MAO-B 和 MAO-A 的IC50值分别为 0.0224、0.0412 和 0.1116 μM。Dual AChE-MAO B-IN-5 具有抗氧化活性,防止 β-淀粉样斑块聚集。Dual AChE-MAO B-IN-5 可用于阿尔茨海默病 (AD) 研究。 | |||
T78541 |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat TFA
MOG (35-55) (TFA) |
||
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) TFA 是一种具有致脑炎活性的化合物,能够诱导 T 细胞增殖和 Th1 细胞因子反应,并促使产生相对较高水平的 IgG 抗体。此化合物作为中枢神经鞘的次要成分,可触发带有广泛斑块样脱髓鞘的复发缓解性神经系统疾病。 | |||
T63559 | IRAK4-IN-22 | ||
IRAK4-IN-22 是选择性的、口服具有活力的、强效的 IRAK4 抑制剂,能够作用于 IRAK4 (IC50: 3 nM) 和 TAK1 (IC50: 17 nM)。IRAK4-IN-21 对 IL-23 的产生表现出有效的抑制作用,其 IC50值为0.10 μM。IRAK4-IN-21 能够用于研究自身免疫性疾病,如斑块状银屑病和银屑病关节炎。 | |||
T78542 |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate
MOG (35-55) (acetate) |
||
Myelin Oligodendrocyte GlycoproteinPeptide (35-55), mouse, rat (MOG (35-55)) acetate 是一中枢神经系统髓鞘的非主要成分,它显示出致脑炎活性,并能诱导 T 细胞增殖。此外,MOG (35-55) acetate 能够诱导 Th1 细胞因子反应,并促使相对高水平的 IgG 抗体生成。它也可能引起复发性和缓解性的神经系统疾病,并伴随广泛的斑块样脱髓鞘现象。 | |||
T83710 |
Gastric Inhibitory Peptide (22-51) (human) TFA
GIP (22-51),Glucose-dependent Insulinotropic Peptide (22-51) |
||
胃抑制肽(GIP) (22-51) 是一种具有30个氨基酸的前动脉硬化肽,对应于GIP前体蛋白proGIP的第22至51个氨基酸残基,已在人类血浆中发现。在1 µM的浓度下使用,该肽能引起在巨峰细胞分化的THP-1细胞和分离的人类主动脉内皮细胞中IκB-α的降解和NF-κB的核转移。在体内,GIP (22-51) 增加了ApoE-/-小鼠的动脉粥样硬化病变面积和斑块形成。 | |||
T72454 |
AChE/BChE/MAO-B-IN-4
|
||
AChE/BChE/MAO-B-IN-4 是一种 1-茚满酮衍生物,是一种有效的MAO-B 抑制剂,对人MAO-B 的IC50为 0.0359 μM。AChE/BChE/MAO-B-IN-4 是一种有效的AChE 和BChE 酶抑制剂,对人AChE 和BChE 酶的IC50值分别为 0.0473 μM 和 0.0782 μM。AChE/BChE/MAO-B-IN-4 显示出显着的抗氧化活性,并防止β-淀粉样蛋白斑块聚集。AChE/BChE/MAO-B-IN-4 具有用于阿尔茨海默病 (AD) 研究的潜力。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5244 |
Aminomalonic acid
2-Aminopropanedioic Acid,氨基丙二酸,Aminomalonate |
Others; Endogenous Metabolite | Metabolism; Others |
Aminomalonic acid (Aminomalonate) 是氨基内源性代谢产物,在体外能作为来源 Leukemia 5178Y/AR 和小鼠胰腺的 L- 天冬酰胺合成酶的高效抑制剂 (Leukemia 5178Y/AR:Ki= 0.0023 M,小鼠胰腺:Ki= 0.0015 M)。它有潜力用作区分黑素瘤转移的不同阶段生物标志物。 | |||
T4723 |
D-Tagatose
塔格糖,D-(-)-Tagatose,D-塔格糖,d-tagatos |
Others; Endogenous Metabolite | Metabolism; Others |
D-Tagatose (D-(-)-Tagatose) 是自然界中发现的一种罕见的单糖,具有益生元特性。它是研究II 型糖尿病的潜在抗糖尿病药物,也是帮助提升结肠有益细菌、预防结肠癌和抑制胆固醇的益生元。它是蔗糖的替代品,也是口香糖、果汁和饮料等食品中的低热量甜味剂。 | |||
T38015 |
Herquline A
|
||
Herquline A is an alkaloid fungal metabolite originally isolated from P. herquei. It inhibits cell death induced by influenza A strain A/PR/8/34 in MDCK cells with an IC50 value of 10 μg/ml and inhibits viral replication in a plaque assay in a concentration-dependent manner. Herquline A also inhibits platelet aggregation induced by ADP and platelet-activating factor (PAF) in vitro (IC50s = 180 and 240 μM, respectively). |